Plasma CXCL13 levels, which can be used as a marker of GC activity (25), were measured at enrollment and were higher with later stages of infection at diagnosis (P < 0.05 S1 vs. S3 and S4/5; Figure 1B). This evidence concerns the gene CXCL13 and infection.